FDA.reportPublic FDA data

meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]

RxCUI
2711795
RxNorm name
meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
Display name
meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
Full name
meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
dcf1ecd1-08a0-8e47-e053-2a95a90abdc7SYMBRAVO 20 MG / 10 MG Oral Tablet [PSN] · meloxicam 20 MG / rizatriptan 10 MG Oral Tablet [Symbravo] [SBD] · Symbravo (meloxicam 20 MG / rizatriptan 10 MG) Oral Tablet [SY]35These highlights do not include all the information needed to use SYMBRAVO safely and effectively. See full prescribing information for SYMBRAVO. SYMBRAVO (meloxicam and rizatriptan) tablets, for oral use Initial U.S. Approval: 202520251121